Table 1.
Demographic and Injection Drug Use Characteristics of HIV-infected and HIV-uninfected Study Participants (N = 1,052)
Characteristic | HIV-Infected N = 312 |
HIV-Uninfected N = 740 |
P |
---|---|---|---|
Age, years | 0.191 | ||
20-29 | 1 (0.3) | 20 (2.7) | |
30-39 | 43 (13.8) | 82 (11.1) | |
40-49 | 137 (43.9) | 304 (41.1) | |
50-59 | 125 (40.1) | 280 (37.8) | |
≥ 60 | 6 (1.9) | 54 (7.3) | |
Median age | 49 | 49 | |
Sex | 0.078 | ||
Male | 191 (61.2) | 495 (66.9) | |
Female | 121 (38.8) | 245 (33.1) | |
Race | 0.013 | ||
Black | 291 (94.2) | 644 (88.5) | |
White | 13 (4.2) | 69 (9.5) | |
Other | 5 (1.6) | 15 (2.1) | |
Annual income | 0.318 | ||
Less than $5,000 | 233 (74.7) | 539 (72.8) | |
$5,000 – $9,999 | 52 (16.7) | 119 (16.1) | |
$10,000 or more | 17 (5.5) | 63 (8.5) | |
Active injection drug use | |||
By frequency | 0.003 | ||
None | 201 (64.4) | 432 (58.4) | |
Less than daily | 76 (24.4) | 160 (21.6) | |
Daily or greater | 35 (11.2) | 148 (20.0) | |
By type | 0.004 | ||
Heroin alone | 14 (4.5) | 84 (11.4) | |
Cocaine alone | 10 (3.2) | 17 (2.3) | |
Heroin and cocaine | 63 (20.2) | 155 (20.9) | |
Other | 24 (7.7) | 52 (7.0) | |
Age first injected drugs, years | |||
Median (IQR) | 20 (17-24) | 21(17-26) | 0.026 |
Abbreviations: HIV human immunodeficiency virus, IQR interquartile range
Entries in table are number of participants (%), unless otherwise indicated.